We are live on ! Find out more
SFG

SVB Financial Group Portfolio holdings

AUM $434K
1-Year Est. Return 277.67%
This Fund
S&P 500
This Quarter Est. Return
+19.26%
1 Year Est. Return
+277.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$52.9M
AUM Growth
+$638K
Cap. Flow
-$3.17M
Cap. Flow %
-6%
Top 10 Hldgs %
96.7%
Holding
30
New
2
Increased
–
Reduced
9
Closed
6
Avg Time Held
1.7 quarters
Top 10 Avg Time Held
1.4 quarters
Top 20 Avg Time Held
1.6 quarters

Top Buys

Rank Stock Value
1
GLBE icon
Global E Online
GLBE
+$168K
2
MKUL
Molekule Group, Inc. Common Stock
MKUL
+$39.5K

Top Sells

Rank Stock Value
1
FROG icon
JFrog
FROG
+$1.88M
2
PATH icon
UiPath
PATH
+$791K
3
DICE icon
DICE Therapeutics, Inc. Common Stock
DICE
+$251K
4
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$97.4K
5
CGEM icon
Cullinan Oncology
CGEM
+$71.8K

Sector Composition

Rank Sector Weight
1 Financials 68.27%
2 Healthcare 15.67%
3 Technology 13.31%
4 Consumer Discretionary 1.38%
5 Industrials 1.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
COIN icon
1
Coinbase
COIN
$47.6B
$29.1M 55.03%
406,973
– –
2022 Q4
2 quarters
ROOT icon
2
Root
ROOT
$749M
$7M 13.23%
783,012
– –
2022 Q4
2 quarters
OKTA icon
3
Okta
OKTA
$39.7B
$6.93M 13.09%
99,872
– –
2022 Q4
2 quarters
AXSM icon
4
Axsome Therapeutics
AXSM
$8.7B
$2.43M 4.6%
33,849
– –
2022 Q4
2 quarters
GPCR icon
5
Structure Therapeutics
GPCR
$1.71B
$1.47M 2.78%
35,353
– –
2023 Q1
1 quarter
DICE icon
6
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$1.01M 1.91%
21,799
-7,267
-25% -$251K
2022 Q4
2 quarters
CMAX icon
7
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$933K 1.76%
10,000
– –
2022 Q4
2 quarters
OBIO icon
8
Orchestra BioMed
OBIO
$355M
$889K 1.68%
127,068
– –
2023 Q1
1 quarter
MLTX icon
9
MoonLake Immunotherapeutics
MLTX
$909M
$825K 1.56%
16,173
– –
2022 Q4
2 quarters
PL icon
10
Planet Labs
PL
$5.81B
$554K 1.05%
172,097
– –
2022 Q4
2 quarters
ROVR icon
11
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$518K 0.98%
105,534
– –
2022 Q4
2 quarters
GLBE icon
12
Global E Online
GLBE
$6.55B
$209K 0.4%
+5,114
New +$168K
2023 Q2
0 quarters
GBIO icon
13
DELISTED
Generation Bio
GBIO
$153K 0.29%
2,788
-1,252
-31% -$57.5K
2022 Q4
2 quarters
CGEM icon
14
Cullinan Oncology
CGEM
$962M
$145K 0.27%
13,516
-6,758
-33% -$71.8K
2022 Q4
2 quarters
PACB icon
15
Pacific Biosciences
PACB
$653M
$136K 0.26%
10,249
– –
2022 Q4
2 quarters
FIRY icon
16
Firy Inc
FIRY
$206M
$125K 0.24%
13,696
-1
-0% -$12
2022 Q4
2 quarters
MVLA
17
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$118K 0.22%
55,528
-42
-0.1% -$80
2023 Q1
1 quarter
CRBU icon
18
Caribou Biosciences
CRBU
$53.3M
$88K 0.17%
20,714
-6,905
-25% -$31K
2022 Q4
2 quarters
KLRS icon
19
Kalaris Therapeutics
KLRS
$53.8M
$87.8K 0.17%
1,122
-374
-25% -$35.5K
2022 Q4
2 quarters
PRDS
20
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$65K 0.12%
35,923
-20,978
-37% -$38.4K
2022 Q4
2 quarters
MKUL
21
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$49.7K 0.09%
+21,247
New +$39.5K
2023 Q2
0 quarters
ELDN icon
22
Eledon Pharmaceuticals
ELDN
$198M
$24.7K 0.05%
18,025
-8,917
-33% -$18.6K
2022 Q4
2 quarters
VERO icon
23
DELISTED
Venus Concept
VERO
$22.7K 0.04%
970
– –
2022 Q4
2 quarters
GRNA
24
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$5.08K 0.01%
16,950
– –
2022 Q4
2 quarters
FROG icon
25
JFrog
FROG
$12.2B
– –
-95,251
Closed -$1.88M –
1
2

Similar funds

RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
CBFP
Cedar Brook Financial Partners Cleveland, Ohio $698K AUM 46.64% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
SLA
SWaN & Legend Advisors Leesburg, Virginia $841K AUM 23.47% 1-Year Est. Return
SG
Stagwell Group Miami Beach, Florida $913K AUM 49.68% 1-Year Est. Return
AFG
AFS Financial Group Bethesda, Maryland $1.15M AUM 23.97% 1-Year Est. Return
K
Kemper Chicago, Illinois $1.2M AUM 20.64% 1-Year Est. Return
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

SVB Financial Group's Q2 2023 Portfolio in Review

As of Q2 2023, SVB Financial Group held 30 positions worth $52.9M, up 1.2% from $52.3M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

SVB Financial Group withdrew a net $3.17M in Q2 2023, closing 6 positions and reducing 9 holdings. Its most notable exit was JFrog, an estimated $1.88M position sold in full.

By sector, the portfolio is most concentrated in Financials at 68% of assets, up from 59% a quarter earlier, followed by Healthcare and Technology.

Against the trend, SVB Financial Group opened a new position in Global E Online worth $209K.

  • SVB Financial Group's largest Q2 2023 buy was Global E Online: 5,114 shares worth $209K.
  • SVB Financial Group's biggest Q2 2023 reduction was DICE Therapeutics, Inc. Common Stock, cutting an estimated $251K.
  • SVB Financial Group fully exited JFrog in Q2 2023, selling an estimated $1.88M.
  • SVB Financial Group's ten largest holdings make up 97% of its $52.9M portfolio in Q2 2023.
  • SVB Financial Group opened 2 new positions and closed 6 in Q2 2023.
  • SVB Financial Group's portfolio value rose 1.2% quarter-over-quarter to $52.9M.

Based on SVB Financial Group's 13F filing for Q2 2023, filed 11 Aug 2023.